45th Multicenter Airway Research Collaboration

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Massachusetts General Hospital
Study ID
NCT07166939
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Asthma
  • Asthma Acute
  • Asthma Control Level
  • Asthma Exacerbation

Eligibility Criteria

Sex
ALL
Age
18 Years - 54 Years
Healthy Volunteers
Not accepted

Interventions

  • Airsupra — DRUG
    1 dose (2 inhalations) PRN, with maximum of 6 doses (12 inhalations) in a 24-hour period

Study Details

The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

Key Dates

Start date
Nov 7, 2025
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
1,860 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • No Intervention: Usual care
    usual care
  • Active Comparator: Intervention
    Airsupra PRN

Primary Outcome Measure

acute asthma recurrence [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MetroHealthClevelandOhio44109
Charles L Emerman, MD
[email protected]
617-726-5276

Find similar trials in Cleveland, OH

By condition
Asthma
By specialty
PulmonologyLung disease
By research site
MetroHealth· Cleveland, OH

Related Studies